Two new sesquiterpenoids-13-hydroxycurzerenone (1) and 1-oxocurzerenone (2)-have been isolated from the rhizomes of Curcuma zedoaria, together with 13 known compounds (3-15). The structures of two new compounds were determined through spectroscopic and MS analyses. Among the isolated compounds, 13-hydroxycurzerenone (1), 1-oxocurzerenone (2), curzerenone (3), germacrone (4), curcolone (5), procurcumenol (6), ermanin (7), curcumin (8), and a mixture of stigmast-4-en-3,6-dione (12) and stigmasta-4,22-dien-3,6-dione (13) exhibited inhibition (with inhibition % in the range of 21.28%-67.58%) against collagen-induced platelet aggregation at 100 µM. Compounds 1, 5, 7, 8, and the mixture of 12 and 13 inhibited arachidonic acid (AA)-induced platelet aggregation at 100 µM with inhibition % in the range of 23.44%-95.36%.
Introduction
Curcuma zedoaria (Christm.) Rosc. (Zingiberaceae) is a perennial rhizomatous herb indigenous to Bangladesh, Sri Lanka, and India, and is also widely cultivated in China, Japan, Brazil, Nepal, and Thailand. Various sesquiterpenoids [1] [2] [3] [4] , curcuminoids [3] , benzenoids [3] , and their derivatives were isolated from this plant in previous studies. Many of these compounds exhibit anti-inflammatory [1], anti-babesial [2] , cytotoxic [3] , and anti-fungal [4] activities.
In our studies of medicinal plants for in vitro anti-platelet aggregation activity, C. zedoaria was found to be an active species. The MeOH extract of the rhizomes of C. zedoaria displayed antiplatelet aggregation activity. Figure 1 illustrates the structures of two new sesquiterpenoids, 13-hydroxycurzerenone (1) and 1-oxocurzerenone (2) . Thirteen known compounds (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) have been isolated and identified from the rhizomes of C. zedoaria, and their structures are depicted in Figure 2 . 
Results and Discussion
13-Hydroxycurzerenone (1) was isolated as a yellowish oil. Its molecular formula (C15H18O3) was determined on the basis of the quasi-molecular ion at m/z 269.1157 ([M + Na] + , calcd. for C15H18O3Na: 269.1154) in the high-resolution electrospray ionization mass spectrometry (HR-ESI-MS) spectrum (positive-ion mode) and was supported by the 1 H-, 13 C-, and DEPT NMR data. The presence of a conjugated carbonyl group was revealed by the band at 1678 cm −1 in the IR spectrum, which was confirmed by the resonance at δC 194.0 in the 13 C-NMR spectrum. The IR of 1 also showed OH absorption at 3450 cm −1 . The 1 H-NMR spectrum of 1 showed resonances for an aromatic proton (δH 7.09 (1H, s, H-12)), a hydroxymethyl group (δH 4.86 (2H, s, H-13)), a methyl group (δH 1.19 (3H, s, H-14)), a vinyl group (δH 4.96 (1H, d, J = 17.5 Hz, H-2), 4.97 (1H, d, J = 11.0 Hz, H-2), 5.82 (1H, dd, J = 17.5, 11.0 Hz, H-1)), a prop-1-en-2-yl group (δH 1.84 (3H, s, H-15), 4.76 (1H, s, H-3), 5.01 (1H, s, H-3)), a methine proton (δH 3.02 (1H, s, H-5)), and two methylene protons (δ 2.79 (1H, d, J = 17.5 Hz, H-9), 2.91 (1H, d, J = 17.5 Hz, H-9)). Comparison of the 1 H-and 13 C-NMR data (Table 1) of 1 with those of curzerenone (3) [5, 6] suggested that their structures are closely related, except that the 11-hydroxymethyl group [δH 4.86 (2H, s, H-13); δC 52.2 (C-13)] of 1 replaced the 11-methyl group of curzerenone (3) [5, 6] . This was supported by HMBC correlation between H-13 (δH 4.86) and C-7 (δC 120.2), C-11 (δC 116.0), and C-12 (δC 139.6), and NOESY correlations between H-13 (δH 4.86) and H-12 (δH 7.09). The NOESY cross-peaks ( Figure 3 ) between H-1 (δH 5.82)/H-5 (δH 3.02), H-1/Hα-9 (δH 2.79), H-14 (δH 1.19)/Ha-3 (δH 5.01), and H-14/Hβ-9 (δH 2.91) suggested that the 10-vinyl group, H-5, and Hα-9 are α-oriented, and the 10-methyl group, C-5 prop-1-en-2-yl group, and Hβ-9 are β-oriented. The full assignments of 1 H-and 13 C-NMR resonances were supported by 1 H-1 H COSY, DEPT, HSQC, NOESY (Figure 3) , and HMBC ( Figure 3 ) spectral analyses. On the basis of the above data, the structure of 1 was elucidated as 13-hydroxy-curzerenone. 
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Mixture of stigmast-4-en-3,6-dione (12) and stigmasta-4,22-dien-3,6-dione (13 
Materials and Methods

General Experimental Procedures
Melting points were determined on a Yanaco micro-melting point apparatus and were uncorrected. Optical rotations were measured using a Jasco DIP-370 polarimeter (Japan Spectroscopic Corporation, Tokyo, Japan) in CHCl 3 . Ultraviolet (UV) spectra were obtained on a Jasco UV-240 spectrophotometer. Infrared (IR) spectra (neat or KBr) were recorded on a Perkin Elmer 2000 FT-IR spectrometer (Perkin Elmer Corporation, Norwalk, CT, USA). Nuclear magnetic resonance (NMR) spectra, including correlation spectroscopy (COSY), nuclear Overhauser effect spectrometry (NOESY), heteronuclear multiple-bond correlation (HMBC), and heteronuclear single-quantum coherence (HSQC) experiments were acquired using a Varian Unity 400 or a Varian Inova 500 spectrometer (Varian Inc., Palo Alto, CA, USA) operating at 400 and 500 MHz ( 1 H) and 100 and 125 MHz ( 13 C), respectively, with chemical shifts given in ppm (δ) using tetramethylsilane (TMS) as an internal standard. Electrospray ionization (ESI) and high-resolution electrospray ionization (HR-ESI)-mass spectra were recorded on a Bruker APEX II (Bruker, Bremen, Germany) or a VG Platform Electrospray ESI/MS mass spectrometer (Fison, Villeurbanne, France). Silica gel (70-230, 230-400 mesh, Merck) was used for column chromatography (CC). Silica gel 60 F-254 (Merck, Darmstadt, Germany) was used for thin-layer chromatography (TLC) and preparative thin-layer chromatography (PTLC).
Plant Material
The rhizomes of C. zedoaria were collected from Yanpu Township, Pingtung County, Taiwan, in September 2012 and identified by Prof. Jih-Jung Chen. A voucher specimen (CZ-201209) was deposited in the Department of Pharmacy, Tajen University, Pingtung, Taiwan.
Extraction and Isolation
The dried rhizomes (3.2 kg) of C. zedoaria were extracted three times with MeOH (12 L each) for 3 days. The extract was concentrated under reduced pressure at 35 • C, and the residue (285 g) was partitioned between EtOAc and H 2 O (1:1) to provide the EtOAc-soluble fraction (fraction A; 98 g). The H 2 O-soluble fraction was further extracted with BuOH, and the BuOH-soluble part (fraction B; 89 g) and the H 2 O-soluble one (fraction C; 95 g) were separated. Fraction A (98 g) was purified by CC (4.4 kg of SiO 2 , 70-230 mesh; n-hexane/acetone gradient) to afford 12 fractions: A1-A12. Fraction A3 (7.8 g) was subjected to CC (355 g of SiO 2 , 230-400 mesh; n-hexane/acetone 30:1-0:1, 800 mL-fractions) to give 10 subfractions: A3-1-A3-10. Fraction A3-4 (155 mg) was purified by preparative TLC (SiO 2 ; CHCl 3 /acetone 50:1) to obtain 1-oleoyl-2,3-distearoylglycerol (9) (4.2 mg) (R f = 0.72). Fraction A3-5 (176 mg) was further purified by preparative TLC (SiO 2 ; n-hexane/EtOAc 35:1) to obtain germacrone (4) (5.2 mg) (R f = 0.48). Fraction A3-6 (185 mg) was further purified by preparative TLC (SiO 2 ; CHCl 3 /acetone 60:1) to afford curzerenone (3) (4.6 mg) (R f = 0.69). Fraction A4 (8.1 g) was subjected to CC (365 g of SiO 2 , 230-400 mesh; n-hexane/EtOAc 20:1-0:1, 900 mL-fractions) to give 11 subfractions: A4-1-A4-11. Part (154 mg) of fraction A4-2 was further purified by preparative TLC (SiO 2 ; n-hexane/EtOAc 7:1) to obtain 1-oxocurzerenone (2) (4.0 mg). Part (164 mg) of fraction A4-3 was further purified by preparative TLC (SiO 2 ; n-hexane/acetone 5:1) to obtain curcolone (5) (4.5 mg) (R f = 0.33). Part (171 mg) of fraction A4-5 was further purified by preparative TLC (SiO 2 ; n-hexane/EtOAc, 8:1) to yield procurcumenol (6) (5.4 mg). Fraction A5 (7.5 g) was subjected to CC (340 g of SiO 2 , 230-400 mesh; CHCl 3 /acetone 15:1-0:1, 950 mL-fractions) to afford nine subfractions: A5-1-A5-9. Fraction A5-4 (365 mg) was purified by MPLC (silica column, CHCl 3 /acetone, 10:1-0:1) to afford six subfractions (each 160 mL, A5-4-1-A5-4-6). Fraction A5-4-3 (52 mg) was purified by preparative TLC (silica gel, CH 2 Cl 2 /acetone, 30:1) to obtain 13-hydroxycurzerenone (1) (3.3 mg) . Fraction A5-4-4 (58 mg) was further purified by preparative TLC (SiO 2 ; CHCl 3 /acetone, 50:1) to afford a mixture of β-sitosterol (10) and stigmasterol (11) (14.3 mg) (R f = 0.56). Part (146 mg) of fraction A5-6 was further purified by preparative TLC (SiO 2 ; n-hexane/acetone, 10:1) to obtain a mixture of stigmast-4-en-3,6-dione (12) and stigmasta-4,22-dien-3,6-dione (13) (11.8 mg) (R f = 0.38). Fraction A7 (8.1 g) was subjected to CC (420 g of SiO 2 , 230-400 mesh; CH 2 Cl 2 /acetone 10:1-0:1, 950 mL-fractions) to afford 10 subfractions: A7-1-A7-10. Part (154 mg) of fraction A7-6 was purified by preparative TLC (SiO 2 ; n-hexane/acetone, 8:1) to obtain a mixture of 6β-hydroxystigmast-4-en-3-one (14) and 6β-hydroxystigmasta-4,22-dien-3-one (15) (10.5 mg) (R f = 0.22). Fraction A7-7 (338 mg) was purified by MPLC (silica column, CHCl 3 /MeOH, 10:1-0:1) to afford eight subfractions (each 110 mL, A7-7-1-A7-7-8). Fraction A7-7-4 (48 mg) was purified by preparative TLC (silica gel, CHCl 3 /acetone, 1:1) to yield ermanin (= 3,4 -dimethoxykaempferol) (7) (4.5 mg) (R f = 0.78). Fraction A8 (6.9 g) was subjected to CC (315 g of SiO 2 , 230-400 mesh; CH 2 Cl 2 /MeOH 8:1-0:1, 800 mL fractions) to afford 11 subfractions: A8-1-A8-11. Part (127 mg) of fraction A8-2 was further purified by preparative TLC (SiO 2 ; CHCl 3 /acetone, 15:1) to yield curcumin (8) (4.7 mg) (R f = 0.68). Part (136 mg) of fraction A8-3 was further purified by preparative TLC (SiO 2 ; CH 2 Cl 2 /acetone, 1:1) to afford ermanin (7) (3.5 mg) (R f = 0.79). 
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